GUMDROP : HUH - Phase I and II Study of Safety and Efficacy of Muscadine Plus, MPX, in Men with Prostate Cancer- A Randomized Dose-Finding Study of 2 Doses of MPX on Rising PSA following Initial Therapy

Created by Nancy Dawson, last modified on Sep 18, 2013
Description:This research is being done to test an investigational product called Muscadine Plus in the treatment of men who have received initial therapy (surgery and or radiation, cryotherapy or brachytherapy) for prostate cancer and are experiencing a rise in their prostate-specific antigens (PSA) level.
Link:http://clinicaltrials.gov/ct2/show/NCT01317199
Site:Howard University Hospital
Principle Investigator:Anita Aggarwal, DO., Ph.D